Novel PD-1 Binding Domains

European Patent Office published patent application EP4314062A1 titled 'Novel PD-1 Binding Domains' on March 25, 2026. The application names Merus B.V. and Incyte Corporation as applicants and covers immunological binding domains (IPC C07K 16/28) with designated states across the European region including DE, FR, GB, NL, and other EU member states.

This is a patent publication notice rather than a regulatory action requiring compliance. Entities in the pharmaceutical and biotechnology sectors developing PD-1/PD-L1 related therapeutics may wish to review this publication for potential freedom-to-operate implications or competitive landscape awareness. No immediate action is required as this represents a patent disclosure, not an enforceable regulatory requirement.